These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 28850614)

  • 1. Nitazoxanide is active against Mycobacterium leprae.
    Bailey MA; Na H; Duthie MS; Gillis TP; Lahiri R; Parish T
    PLoS One; 2017; 12(8):e0184107. PubMed ID: 28850614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug resistance in leprosy.
    Matsuoka M
    Jpn J Infect Dis; 2010 Jan; 63(1):1-7. PubMed ID: 20093754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The activity of several newer antimicrobials against logarithmically multiplying M. leprae in mice.
    Burgos J; de la Cruz E; Paredes R; Andaya CR; Gelber RH
    Lepr Rev; 2011 Sep; 82(3):253-8. PubMed ID: 22125933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The bactericidal activity of various aminoglycoside antibiotics against Mycobacterium leprae in mice.
    Gelber RH; Henika PR; Gibson JB
    Lepr Rev; 1984 Dec; 55(4):341-7. PubMed ID: 6396475
    [No Abstract]   [Full Text] [Related]  

  • 5. Activity of selected beta-lactam antibiotics against Mycobacterium leprae.
    Shepard CC; Van Landingham RM; Walker LL; Good RC
    Int J Lepr Other Mycobact Dis; 1987 Jun; 55(2):322-7. PubMed ID: 3298478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bactericidal activities of HMR 3647, moxifloxacin, and rifapentine against Mycobacterium leprae in mice.
    Consigny S; Bentoucha A; Bonnafous P; Grosset J; Ji B
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2919-21. PubMed ID: 10991891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The activity of rifabutin against Mycobacterium leprae in armadillos.
    Dhople AM; Williams SL
    Int J Antimicrob Agents; 1997 Jan; 9(3):169-73. PubMed ID: 9552713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mycobacterium leprae is naturally resistant to PA-824.
    Manjunatha UH; Lahiri R; Randhawa B; Dowd CS; Krahenbuhl JL; Barry CE
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3350-4. PubMed ID: 17005816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activity of rifabutin against Mycobacterium leprae.
    Yoder LJ; Jacobson RR; Hastings RC
    Lepr Rev; 1991 Sep; 62(3):280-7. PubMed ID: 1665534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro synergistic activity between ofloxacin and ansamycins against Mycobacterium leprae.
    Dhople AM; Ibanez MA; Gardner GD
    Arzneimittelforschung; 1993 Mar; 43(3):384-6. PubMed ID: 8387790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further studies of the action of antithyroid drugs on Mycobacterium leprae.
    Levy L; Anandan JA
    Proc Soc Exp Biol Med; 1978 Sep; 158(4):582-5. PubMed ID: 80802
    [No Abstract]   [Full Text] [Related]  

  • 12. Activities of various macrolide antibiotics against Mycobacterium leprae infection in mice.
    Gelber RH; Siu P; Tsang M; Murray LP
    Antimicrob Agents Chemother; 1991 Apr; 35(4):760-3. PubMed ID: 1648889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo experiments with the new inhibitor of mycobacterium leprae brodimoprim alone and in combination with dapsone.
    Seydel JK; Wempe EG; Rosenfeld M; Jagannathan R; Mahadevan PR; Dhople AM
    Arzneimittelforschung; 1990 Jan; 40(1):69-75. PubMed ID: 2187440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo effects of N-methyl-3,5-dichloro-benzylamine hydrochloride on Mycobacterium leprae.
    Dhople AM; Strong LC; Meindl W; Schoenenberger H; Gardner GD
    Arzneimittelforschung; 1991 Mar; 41(3):253-6. PubMed ID: 1867663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of enhancing effect of trimethoprim on the activity of a sulfonamide against Mycobacterium leprae.
    Pattyn SR; Verdoolaege-Van Loo G
    Int J Lepr Other Mycobact Dis; 1972; 40(3):320. PubMed ID: 4574275
    [No Abstract]   [Full Text] [Related]  

  • 16. Bactericidal activities of single or multiple doses of various combinations of new antileprosy drugs and/or rifampin against M. leprae in mice.
    Ji B; Perani EG; Petinon C; Grosset JH
    Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):556-61. PubMed ID: 1338596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of rifampicin and dapsone on experimental Mycobacterium leprae infections: minimum inhibitory concentrations and bactericidal action.
    Holmes IB; Hilson GR
    J Med Microbiol; 1972 May; 5(2):251-61. PubMed ID: 4555734
    [No Abstract]   [Full Text] [Related]  

  • 18. The activity of a thiadiazole on Mycobacterium leprae.
    Levy L
    Proc Soc Exp Biol Med; 1976 Oct; 153(1):34-6. PubMed ID: 792890
    [No Abstract]   [Full Text] [Related]  

  • 19. Multidrug resistant Mycobacterium leprae from patients with leprosy.
    Maeda S; Matsuoka M; Nakata N; Kai M; Maeda Y; Hashimoto K; Kimura H; Kobayashi K; Kashiwabara Y
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3635-9. PubMed ID: 11709358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Advances in the chemotherapy of leprosy].
    Grosset J
    Med Trop (Mars); 1984; 44(1):17-22. PubMed ID: 6377002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.